Uncategorized
EyeGate receives grant to continue development of ocular bandage film
Jade Therapeutics, a subsidiary of EyeGate Pharmaceuticals, received $448,185 in funding from the U.S. Army Medical Research and Materiel Command for a second year, EyeGate announced. The funding will be used to continue developing a proprietary thiolated hyaluronic acid (CMHA-S) product, which is under study for use as an ocular bandage film, and brings the total funding Jade has received from the U.S. Army’s Small Business Innovation Research program to $1.25 million, according to a press release.